French GP platform Doctolib has acquired London-based peer Medicus and plans to invest more than 拢100 million in the UK.
The deal, for an undisclosed amount, will see Doctolib deliver their combined technology, AI and services to the clinical and administrative teams of GP practices across the country.
Its plans include the hiring of 150 people and establishment of a full R&D centre in London to drive innovation in primary care.
Medicus will continue to operate with founder and CEO Emile Axelrad at the helm, and keep its UK-based team in place.
The firm introduced the first new GP clinical software system in the NHS in 25 years after it was developed through NHS England鈥檚 Tech Innovation Framework. The platform is designed to meet national requirements and integrate with key health systems, including the NHS App.
鈥淭his is an important step for Medicus, for the GP practices we support and for the future of primary care in the UK,鈥� said Axelrad.
鈥淏y joining forces with Doctolib, we will strengthen the platform, accelerate innovation and give practices access to even greater product and service capabilities, while preserving the quality, proximity and understanding they already value from our team.
鈥淭ogether, as a British team, we want to raise the standard for GP technology across the UK.鈥�
Doctolib, which claims to have a suite of AI assistants, currently serves more than 40,000 GPs, 500,000 total health professionals and 1,000 hospitals across Europe.
Stanislas Niox-Chateau, co-founder and CEO of Doctolib, said: 鈥淢edicus has built an impressive product and team for UK general practices.
鈥淏y joining forces, we are becoming one team with one ambition: give GP practices in the UK the best technology, AI and services to simplify work, improve coordination and help professionals spend more time caring for patients. We are making a long-term commitment to the UK.
鈥淲e plan to invest more than 拢100 million in the UK over the coming years, hire 150 people in London, establish a dedicated R&D center, and bring the full power of our expertise, including our AI clinical lab, to support innovation in NHS primary care.鈥�